The Transplantation Society (TTS)

✨Meet the #TTS2026 Plenary Speakers!✨

🗣️Maria Grazia Roncarolo, Tatsuo Kawai, Anoma Nellore, Richard N. Pierson III, Wayne J. Hawthorne, Luz Padilla, John J. Fung, Haibo Wang, Ton J. Rabellink, and Olivia Smibert

Don't miss this event! 🔗https://tts2026.org/

Figure showing an overview of VEXAS syndrome. The clinical phenotype is expanding and the pathobiology of some manifestations have been elucidated. VEXAS=vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic.

VEXAS syndrome is a newly discovered multisystemic disease affecting most organs.

A Review provides a comprehensive overview of VEXAS syndrome, including the disease's discovery, diagnosis, and treatment: spkl.io/63322AsNa8

Our most-read paper! International experts reached new consensus guidance on managing immunosuppression to reduce skin cancer risk in kidney transplant recipients—highlighting when to adjust therapy and the importance of close dermatology collaboration. tinyurl.com/2tbfye8p

⏱️ It's time to nominate for TTS leadership!

Open positions include👉

3 Officers:
🔹President-Elect
🔹Vice President
🔹Treasurer

5 Regional Councilors-at-large:
🔹Africa (1)
🔹Latin America (2)
🔹North America (1)
🔹Europe (1)

🚨Noms due 18 Feb!

Learn more 🔗 www.tts.org/nominations

Safer, more durable kidney transplants were the focus at #WTC2025. Discussions centered on personalized immunosuppression, innovative trial designs, managing side effects, and improving adherence through patient education. #TXPforAll #Immunosuppression tinyurl.com/3czwpkmb

🔔Webinar recordings now available!

💡Topics:
🔹To Vaccinate or Not To Vaccinate: Who is the Question
🔹 How Regenerative Medicine Will Redefine Transplantation
🔹 Desensitization with Imlifidase
🔹 Implementing Molecular Diagnostics in Kidney Transplant Care

View here 👉 tts.org/education/tt...

🌟Share your science on a global stage 🌏

Submit your abstract to #TTS2026 and connect with leading experts moving the field forward🚀

✔️Submit by March 19, 2026

Submit here🔗https://tts2026.org/program/call-for-abstracts

This paper, which is available to download for free, notes that empowered patient and family volunteers are essential for effective and equitable transplant policies within the OPTN. #TXPforAll #Transplantation tinyurl.com/b9bh75w2

Graph showing use of AI stethoscope examinations (cardiac waveform recordings for AI interpretation) among recruited GP practices in the intervention group (n=96) during the first 12 months of implementation. Stacked bars represent the number of practices (y-axis, left) stratified by usage intensity category: high users (≥31 uses per month), medium users (10–30 uses per month), low users (<10 uses per month), and non-users (0 uses per month). Darker shades within each bar denote higher usage categories, with high users shown in the darkest shade. The overlaid line graph indicates cumulative number of AI stethoscope examinations (y-axis, right) over 12 months, with numbers above each bar denoting the total number of onboarded practices at that timepoint. AI=artificial intelligence. GP=general practitioner.

🆕 AI-enabled stethoscopes show promise for improving diagnosis of cardiovascular conditions, UK trial finds.

Find out more: spkl.io/63324AS3BE

🚨 Don't miss the latest Behind the Paper with Dr. Gerald Brandacher!

💡 Watch or listen to an interview about the evolving field of vascularized composite allotransplantation, and Brandacher's recent review on chronic rejection

👉 tinyurl.com/kcj92639

@transplantation.bsky.social

#TBT to this week's featured top downloaded paper from 2022: Advances in Kidney Preservation Techniques and Their Application in Clinical Practice #TXPforAll #Transplantation #Med tinyurl.com/4syckhzw

🔔Pediatric-focused webinar tomorrow, starting at 8 am!

Join here 🔗 tts.org/ipta-educati...

🌟Don't miss this week's #TTSPulse!

🔹TTS2026 abstract submissions are open!

🔹New podcast 👉 Behind the Paper with Gerald Brandacher

🔹Call for TTS leadership nominations - Due 18 Feb!

🔹Upcoming webinars plus recordings

Read here 🔗 tinyurl.com/4cszsrps

Celebrating Professor Jeremy Chapman, former Editor-in-Chief of *Transplantation*, as he reflects on his remarkable career and lifelong contributions to the field in a newly published paper. #TXPforAll #Transplantation tinyurl.com/mr4bvwdu

🔔There's still time to join today's webinar, starting at 4 pm (ET)!

Topic 👉 How Regenerative Medicine Will Redefine Transplantation by 2050

Join here 🔗 tinyurl.com/u8xz7zjb

Quote from a Comment published in The Lancet. Quote reads: These shifts can thus serve as a valuable overarching compass for joint global health reform efforts, steering the conversation from what needs changing to how to do it in practice.

"Struck by substantial funding cuts throughout 2025, the global health community stands at a crossroads."

A new Comment outlines four key paradigm shifts that could guide the transformation of the global health system: spkl.io/63325AUMj5

Change in Estimated GFR and Risk of Allograft Failure in... : Transplantation owing the diagnosis of AMR and the risk of subsequent death-censored graft failure using the joint modeling framework. We included recipients of solitary KTx between 1995 and 2013 at 4 transplant centers diagnosed with biopsy-proven active AMR at least 1 year post-KTx, who had a minimum of 3-year follow-up. Results. A total of 91 patients across participating centers were included in the analysis. Of the 91 patients, n = 54 patients (59%) met the death-censored graft failure endpoint and n = 62 patients (68%) met the all-cause graft failure composite endpoint. Kaplan-Meier death-censored graft survival rates at 12, 36, and 60 months postdiagnosis of AMR pooled across centers were 88.9%, 58.9%, and 36.4%, respectively. Spaghetti plots indicated a linear trend in the change in eGFR, especially in the first 12 months postdiagnosis of active AMR. A significant change in eGFR was observed within the first 12 months postdiagnosis of active AMR, getting worse by a factor of −0.757 mL/min/1.73 m2 per month during the 12-month analysis period (a delta of −9.084 mL/min/1.73 m2 at 1 y). Notably, an extrapolated 30% improvement in the slope of eGFR in the first 12 months was associated with a 10% improvement in death-censored graft failure at 5 years. Conclusions. If prospectively validated, this study may inform the design of pivotal clinical trials for therapies for late AMR....

#TBT to this week's featured top downloaded paper from 2022: Change in Estimated GFR and Risk of Allograft Failure in Patients Diagnosed With Late Active Antibody-mediated Rejection Following Kidney Transplantation #Transplantation #Med tinyurl.com/3n5wx6aj

🌟TTS 2026 abstract submission is now open! 🌟

We are thrilled to open abstract submissions for #TTS2026 in Sydney, Sept. 20-23! 🌏

✅ Deadline: March 19
Learn more 🔗 tts2026.org/program/call...

💡Did you know IPTA has a ListServ for medical queries? IPTA members can tap into the knowledge of our international pediatric community and share clinical expertise to better serve patients. 🌍 ❤️

Learn more 🔗 tts.org/ipta-members...

Not an IPTA member? DM us for more info!

🔔Upcoming webinar - Save the date!

Topic 👉 Desensitization with Imlifidase

💬 Shyam Bihari Bansal, Dirk Kuypers, Marie-Paule Emonds

💡Hear about the publication of the Belgian Consensus Guidelines on the use of Imlifidase.

📅 Weds., Jan. 21 - 8 am (ET)

🔗 tinyurl.com/3pd6errw

#TBT to this week's featured top downloaded paper from 2022: Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration #Transplantation #Med tinyurl.com/2utdznfy

Figure summarising the mechanisms of action targeted for MASH therapy. MASH=metabolic dysfunction-associated steatotic liver disease. Copyright: 2025 Elsevier Ltd. All rights are reserved.

Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease.

In @lancetgastrohep.bsky.social, a new Review summarises recent breakthroughs and potential future developments: spkl.io/63326Amv4o

Don't miss this week's #TTSPulse! Here's a peek inside:

🔹 @transplantation.bsky.social January issue release
🔹Behind the Paper interview
🔹#TTS2026 updates
🔹Upcoming webinars
🔹Transplantation in the news and more!

🔗 tinyurl.com/3m46n48c

🌟 Call for nominations 🌟

We're now accepting nominations for TTS leadership, including 👉

3⃣ Officers:
🔹President-Elect
🔹Vice President
🔹Treasurer

5⃣ Regional Councilors-at-large

Learn more 🔗 www.tts.org/nominations

✅ Due 18 Feb

🌟Interested in collaborating with transplantation professionals in your field? Join an IPTA community!

We've organized organ-specific communities that bring experts together for meaningful discussions through an easy-to-join call.

Learn more 🔗 tts.org/ipta-about/i...

This new international consensus recommends making drug adjustments earlier and collaborating more closely with dermatologists to protect kidney transplant recipients from skin cancer. #TXPforAll #Transplantation tinyurl.com/mvah9bc6

Webinar announcement 👉 Hand Transplants – Current Status and Future Prospects

📅 Friday, Dec.19 at 7 am (ET)

💬 Mohit Sharma, David Leonard, Selva Seetharaman

💡Join to learn...
🔹Status of hand transplants
🔹Lessons learned from UK and India
🔹Challenges and solutions

🔗 tinyurl.com/3vsbu75a

#TBT to this week's featured top downloaded paper from 2022: Ethical Challenges and the Donation Physician Specialist
A Scoping Review #Transplantation #Med tinyurl.com/yca2tw9b

Aging reshapes immunity. Our new review highlights how immunosenescence influences kidney transplant outcomes and why senolytics may offer future therapeutic promise. TXPforAll #Immunology #OpenAccess tinyurl.com/23s2x4dp

ML can predict 1-yr graft survival in German liver transplant data—but the model collapsed when tested on US patients.
❗Different donors, different recipients, different outcomes.
📌 ML tools must be validated locally before they’re used clinically tinyurl.com/56ctu8sz